The formation of stones in the urinary tract stems from a wide range of underlying disorders. That clinicians look for the underlying causes for nephrolithiasis is imperative to direct management. There are many advances in genetics, pathophysiology, diagnostic imaging, medical treatment, medical prevention, and surgical intervention of nephrolithiasis. Here, I provide
a brief general background and focus mainly on pathophysiology and medical treatment of kidney stones. Although important advances have been made in understanding nephrolithiasis from single gene defects, the understanding of polygenetic causes of kidney stones is still largely elusive. A substantial proportion of data that resulted in new methods of treatment and prevention, which can be empirical or definitive, has focused on urinary luminal chemical composition of the precipitating solutes.
Manipulation of inhibitors and epithelial factors is important and needs further investigation. Advances in the management of nephrolithiasis depend on combined efforts of clinicians and scientists to understand the pathophysiology. To read this article in full you will need to make a payment Kidney stones. Nephrolithiasis. Prehistoric or predynastic
Egyptian calculus. Urolithiasis in childhood. Factors
influencing bladder stone formation in patients with spinal cord injury. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. Recurrence after a
single renal stone in a community practice. Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. The natural history of renal and ureteric calculi. Renal stone epidemiology: a 25-year study in Rochester,
Minnesota. Demographic and geographic variability of kidney stones in the United States. Etiological role of estrogen status on renal stone formation. Similarity of urinary risk factors among stone-forming patients in five regions of the United States. Observations on the analysis of ten thousand urinary calculi. Sex- and age-related composition of 10 617 calculi analyzed by infrared
spectroscopy. Urinary tract stone disease in the United States veterans population. I. Geographic frequency of occurrence. Urinary
tract stone disease in the United States veteran population. II. Geographic analysis of variations in composition. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Diagnosis of acute flank pain: value of unenhanced helical CT. Retrospective study of 95 patients with staghorn
calculus disease. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Helical CT for nephrolithiasis and ureterolithiasis: comparison of conventional and reduced radiation-dose techniques. Spiral computed
tomography: role in determination of chemical compositions of pure and mixed urinary stones—an in vitro study. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Nephrolithiasis. Clinical implications of physicochemistry of stone formation.
The origin and growth of renal calculi. Ann Surg. 1937; 105: 1009-1027
Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of henle. J Clin Invest. 2003; 115: 607-616
Urine calcium and volume predict coverage of renal papilla by Randall's plaque. Kidney Int. 2003; 64: 2150-2154
Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol. 2005; 173: 117-119
The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004; 171: 1920-1924
A simple test for the diagnosis of absorptive, resportive and renal hypercalciurias. N Engl J Med. 1975; 292: 497-500
Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab. 1990; 71: 138-145
Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Min Res. 1992; 7: 1383-1388
Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab. 1980; 50: 654-658
Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum. 2002; 32: 64-70
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005; 257: 6-17
The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res. 1998; 13: 1594-1601
Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Metabolism. 1980; 29: 13-17
The potential role of salt abuse on the risk for kidney stone formation. J Urol. 1993; 150: 310-312
Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346: 77-84
Salt intake, urinary sodium, and hypercalciuria. Miner Electrolyte Metab. 1997; 23: 265-268
Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria. Lancet. 1967; 1: 1354-1357
Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003; 12: 122-127
Hypothesizing on the evolutionary origins of salt-induced hypercalciuria. Curr Opin Nephrol Hypertens. 2005; 14: 368-372
Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron. 1999; 81: 18-25
Bone buffering of acid and base in humans. Am J Physiol Renal Physiol. 2003; 285: F811-F832
Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol. 1985; 134: 20-23
The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis. 1997; 29: 291-302
The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci. 1979; 57: 285-288
A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993; 328: 833-838
Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis. 2002; 40: 265-274
Effect of high protein diet on stone-forming propensity and bone loss in rats. Kidney Int. 2003; 64: 2142-2149
Citrate and renal calculi: new insights and future directions. Am J Kidney Dis. 1991; 17: 420-425
Urinary citrates in calcium urolithiasis. Proc Soc Exp Biol. 1941; 46: 216-218
Pathophysiology of hypocitraturic nephrolithiasis.
Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int. 2004; 66: 2032-2037
Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am. 2002; 31: 927-949
Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis. Clin Sci. 1990; 79: 9-15
Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974; 291: 1344-1350
Mechanism for calcium urolithiasis among patients with hyperuricosuria. J Clin Invest. 1977; 59: 426-431
Inherited hyperuricemic disorders. Contrib Nephrol. 2005; 147: 22-34
Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature. 2002; 742: 1-5
Nephrolithiasis in patients with gout. Postgrad Med. 1978; 63: 164-170
Normouricosuric uric acid urolithiasis: a systemic disease with defective renal acidification. Endo Clin North Am. 2002; 31: 895-914
Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int. 2001; 60: 757-761
Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology. 2002; 60: 789-794
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002; 62: 971-979
Biochemical profile of stone formation patients with diabetes mellitus. Urology. 2003; 61: 523-527
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004; 172: 159-163
Nephrolithiasis and the metabolic syndrome: a case-control study.
High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant. 2005; 20: 468-469
Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004; 65: 1422-1425
The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. 2004; 65: 386-392
Amino acid metabolism in cystinuria. Q J Med. 1951; 79: 205-219
Garrod's foresight; our hindsight. J Inherit Metab Dis. 2001; 24: 93-116
Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol. 2005; 20: 19-24
Heteromeric amino acid transporters: biochemistry, genetics and physiology. Am J Physiol. 2001; 281: F995-F1018
Inhibitors of crystallization. Adv Nephrol Necker Hosp. 1995; 24: 167-216
Protein inhibitors of crystallization. Semin Nephrol. 1991; 11: 98-109
Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis. 2004; 44: 963-986
Genetic hypercalciuria. J Am Soc Nephrol. 2005; 16: 729-745
Familial idiopathic hypercalciuria. N Engl J Med. 1979; 300: 337-340
Family history and risk of kidney stones. J Am Soc Nephrol. 1997; 8: 1568-1573
Autosomal dominant inheritance of hypercalciuria. Eur J Pediatr. 1980; 133: 239-242
Familial absorptive hypercalciuria in a large kindred.
The 1 alpha-hydroxylase locus is not linked to calcium stone formation or calciuric phenotypes in French-Canadian families. J Am Soc Nephrol. 1998; 9: 425-432
Suggestive evidence for a susceptibility gene near the vitamin D receptor locus in idiopathic calcium stone formation. J Am Soc Nephrol. 1999; 10: 1007-1013
Influence of calcium-sensing receptor gene on urinary calcium excretion in stone-forming patients. J Am Soc Nephrol. 2002; 13: 2517-2523
No evidence for point mutations of the calcium-sensing receptor in familial idiopathic hypercalciuria. Nephrol Dial Transplant. 2001; 16: 2317-2322
Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis. Kidney Int. 2000; 58: 38-42
Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis. J Urol. 2001; 166: 1484-1486
Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab. 1999; 84: 3907-3913
Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab. 2002; 87: 1476-1485
Molecular etiology of primary hyperoxaluria type 1. Am J Nephrol. 2005; 25: 303-310
Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet. 2002; 107: 176-185
A high prevalence of renal hypuricemia caused by inactive SLC22A12 in Japanese. Kidney Int. 2004; 66: 935-944
Identification of a new candidate locus of uric acid nephrolithiasis. Am J Hum Genet. 2001; 68: 1119-1129
Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate. Am J Hum Genet. 2003; 72: 1479-1491
The amino acid transport system b(o,+) and cystinuria. Mol Membr Biol. 2001; 18: 21-26
From gene to disease; SLC3A1, SLC7A9 and cystinuria. Ned Tijdschr Geneeskd. 2003; 147: 245-247
Surgical management of urolithiasis. Endocrinol Metab Clin North Am. 2002; 31: 1065-1082
Expanding role of ureteroscopy and laser lithotripsy for treatment of proximal ureteral and intrarenal calculi. Curr Opin Urol. 2002; 12: 277-280
Percutaneous nephrolithotomy: an update. Curr Opin Urol. 2003; 13: 235-241
Ureteroscopic treatment of renal calculi. Urol Clin North Am. 2004; 31: 89-98
Factitious renal colic. Urology. 1997; 50: 858-862
Acute renal colic from ureteral calculus. N Engl J Med. 2004; 350: 684-693
Beverage use and risk for kidney stones in women. Ann Intern Med. 1998; 128: 534-540
Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5 year randomized prospective study. J Urol. 1996; 155: 839-843
High salt intake appears to increase bone resorption in postmenopausal women but high potassium intake ameliorates this adverse effect. Nutr Rev. 2003; 61: 179-183
Pathogenesis of hypercalciuric nephrolithiasis. Endocrinol Metab Clin North Am. 2003; 31: 869-884
Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988; 66: 140-146
Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004; 164: 885-891
Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004; 15: 3225-3232
The influence of calcium content of water, intake of vegetables and fruit and of other food factors upon the incidence of renal calculi. Urol Res. 1975; 3: 61-66
Dependence of oxalate absorption on the daily calcium intake.
Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001; 59: 270-276
Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol. 1985; 5: 40-44
A further study of oxalate in foods. J Urol. 1990; 144: 94-96
Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol. 2003; 169: 465-469
Thiazide prophylaxis of urolithiasis: a double blind study in general practice. Acta Med Scand. 1984; 215: 383-389
Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988; 139: 679-684
Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999; 13: 679-685
Use of potassium citrate as potassium supplement during thisazide therapy of calcium nephrolithiasis. J Urol. 1984; 131: 430-433
Long-term combined treatment with thiazide and potassium citrate in nephrolithiasis does not lead to hypokalemia or hypochloremic metabolic alkalosis. Kidney Int. 2003; 63: 240-247
Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993; 22: S78-S86
Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br J Urol. 1996; 78: 176-180
Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994; 20: 371-377
Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int. 1986; 30: 422-428
Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997; 158: 2069-2073
Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986; 315: 1386-1389
Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria hyperuricosuria or no metabolic disorder. Ann Intern Med. 1977; 87: 404-410
Recombinant urate oxidase (rasburicase) in the prophylaxis and treatment of tumor lysis syndrome. Contrib Nephrol. 2005; 147: 69-79
Struvite stones: diagnosis and current treatment concepts. J Endourol. 1999; 13: 653-658
Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci. 2003; 8: e437-e443
Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med. 1994; 331: 1553-1558
Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria. J Urol. 1986; 136: 146-149
Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986; 136: 1003-1008Article InfoPublication HistoryPublished: 28 January 2006 IdentificationDOI: https://doi.org/10.1016/S0140-6736(06)68071-9 Copyright© 2006 Elsevier Ltd. All rights reserved. ScienceDirectAccess this article on ScienceDirectLinked Articles
What is the pathophysiology of nephrolithiasis?Supersaturated urine, acidic urine pH and reductions in kidney stone inhibitors in the urine are the main recognized causes that contribute to the formation of all these stone-types. Nephrolithiasis is considered a systemic pathology that may lead to end-stage renal disease.
What is the most common cause of nephrolithiasis?Oxalate is the most common of these. Oxalate is present in certain foods such as spinach. It is also found in vitamin C supplements. Diseases of the small intestine increase your risk for these stones.
Is urolithiasis the same as nephrolithiasis?Nephrolithiasis refers specifically to kidney stones, although it is broadly used to refer to stones in the urinary tract. Ureterolithiasis, on the other hand, refers to stones within the ureter, and urolithiasis refers to stones in any part of the urinary tract (kidneys, ureter, bladder and urethra).
What is nephrolithiasis and the signs and symptoms?Common symptoms include severe pain in lower back, blood in your urine, nausea, vomiting, fever and chills, or urine that smells bad or looks cloudy. Urine has various wastes dissolved in it.
|
Nephrolithiasis pathophysiology
Postagens relacionadas
direito autoral © 2024 cemle Inc.
